NextGen Omics & Spatial Biology US 2025

27 - 28 March 2025 | Boston, MA

Leveraging multi-omic data to unlock transformative insights into cellular biology, disease and drug discovery

Omics Hero Banner Circle Image
Overview NGS, Clinical Omics & Diagnostics Single Cell Spatial Multi-Omics

Explore NextGen Omics & Spatial Biology US 2025: Advancing Therapeutic Innovation Through Multi-Omics Research 

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

NGS, Clinical Omics & Diagnostics

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through Next Generation Sequencing & Clinical Diagnostics, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

  • Over 600 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 50 presentations focussed on the critical issues in NGS implementation and data integration
  • Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets
  • Discuss digital PCR & liquid biopsies. Hear from key opinion leaders’ in-depth presentations on PCR machines for NGS library preparation, developing nextgen MRD assays and advances in analysing cell-free DNA & CTCs  

Agenda at a Glance


  • Day One | Track 1: Advanced Sequencing Technologies
  • Day One | Track 2: Multi Omics Data Harmonization, Integration & Analysis
  • Day One | Track 3: Applying Multi-Omics in the Clinic
  • Day Two | Track 1: Novel Diagnostics For Infectious & Non-Infectious Disease

 

Single Cell Analysis

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join Single Cell Analysis to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

  • Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery
  • Advance your understanding emerging single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics updates

Agenda at a Glance


  • Day One | Track 4: Emerging Single Cell Technologies
  • Day Two | Track 2: Bioinformatics For Single Cell Analysis
  • Day Two | Track 3: Applications Of Single Cell Technologies

Spatial Multi-Omics

Unlocking the Potential of Spatial Technologies 

Spatial Multi Omics are transforming drug development, allowing researchers to more precisely understand biological systems than ever before. At Spatial US, experts from across leading academic institutions and biopharma organizations showcase the most transformative spatial tools and their applications in target identification, biomarker discovery, translational research & clinical design. From data analytics to successful therapeutic case studies, it equips you with the information you need to successfully adopt spatial technologies into your workflows. 

  • Hear from and meet with the key innovators in spatial multi-omics. 2024 attendees included: Distinguished University Professor, George Mason University; Senior Scientist, AbbVie; Principal Scientist, Boehringer Ingelheim
  • New to 2025! Gain invaluable insights into novel multi-omics technologies for spatial genomics & transcriptomics. Presentations will include translating spatial imaging techniques & approaches into drug development multi-modality processing and spatial transcriptomic databases
  • New to 2025! Discuss spatial biology for oncology, immunology and neuroscience. Hear from expert speakers discussing the tumour environment, distribution of immune cells within the tumour and mapping cellular diversity in the brain  
  • New to 2025! Advance your understanding on novel multi-omics technologies for spatial proteomics & metabolomics: from developing novel technologies for protein analysis through to automated multi-omics workflows, spatial distribution of proteins within cell and distribution of metabolites at spatial resolution
  • Join a series of workshops, panel discussions & roundtables. Discussion sessions will include: ‘Overcoming the Challenges of Spatial Data Analysis’

Agenda at a Glance


  • Day One | Track 5: Novel Multi-Omic Technologies: Spatial Genomics & Transcriptomics
  • Day One | Track 6: Spatial Biology for Therapeutic Discovery & Development
  • Day Two | Track 4: Novel Multi-Omic Technologies: Spatial Proteomics & Metabolomics
  • Day Two | Track 5: Spatial Biology for Therapeutic Discovery & Development

 

What to Expect

1000

leading pharma, biotech, & academic delegates

60
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
62
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

NextGen Omics & Spatial Biology US 2025 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Aleksandra Markovets
Director,
AstraZeneca
Colles Price
Scientific Associate Director,
Takeda
Giorgio Gaglia
Senior Principal Scientist,
Sanofi
Jasmine Plummer
Director,
St Jude Children's Research Hospital
Maxime Dhainaut
Director of Functional Genomics,
Noetik
Pascaline Mary
Senior Director,
HiFiBiO Therapeutics
Priya Chockalingam
Vice President, Head of Clinical Bioanalytics & Translational Sciences,
Beam Therapeutics
Robert Green
Director, Genomes2People Research Program,
Brigham and Women's Hospital
Simona Cristea
Head of Data Science,
DFCI
Wenning Qin
Senior Vice President Innovation,
eGenesis
Yuchun Guo
Director of Computational Biology and Machine Learning,
Camp4 Therapeutics
Zora Modrusan
Sr. Director NGS,
Genentech
Alexandra Tsolias
Scientist II,
Voyager Therapeutics
Ali Ebrahimi
Associate Director,
Takeda
Alice Wan
Senior Scientist,
Abbvie
Alina Ainbinder
Principal Scientist,
Takeda
Aridaman Pandit
Senior Principal Research Scientist,
Abbvie
Brian Cunningham
Professor,
University of Illinios
Deidre Dalmas Wilk
Director,
GSK
Dongdong Lin
Scientist,
EMD Serono
Elaine Lim
Assistant Professor,
UMass Chan Medical School
Elsa Molina
Director, Single-Cell & Spatial Omics,
Salk Institute
Emre Arslan
Associate Director,
Takeda
Eugean Jiwanmall
Senior Research Analyst,
Independence Blue Cross
Felix Francis
Senior Manager Data Management and Analytics,
Takeda
Gabor Balazsi
Professor,
Stony Brook University
Gang Wu
Associate Member,
St Jude Children's Research Hospital
Guolin Zhang
Principal Scientist,
Sensei Therapeutics
Ioannis Ragoussis
Professor,
McGill university
iulian Pruteanu-Malinici
Senior Director Bioinformatics,
Flagship Pioneering
Jan Schejbal
Senior Scientist I,
AbbVie
Jia-Ren Lin
Director,
LSP, Harvard Medical School
Jun Wang
Associate Professor,
Stony Brook University
Kalotina Machini
Principal Investigator (Variant/Genomics) & Instructor in Pathology,
Harvard University
Kalpana Pillai
Technical Development Principal Scientist,
Genentech
Kieran Campbell
Assistant Professor & Research Group Lead,
University of Toronto & Lunenfeld-Tanenbaum Research Institute
Kimberly Smythe
Scientist,
Fred Hutchinson Cancer Center
Lana Garmire
Associate Professor,
University of Michigan
Leonora Balaj
Assistant Professor,
Massachusetts General Hospital
Limeng Pu
Senior Computational Research Scientist,
St. Jude Children's Research Hospital
Lin Wu
Director, Genome Modification Facility,
Harvard University
Luca Pinello
Associate Professor of Pathology,
HARVARD MEDICAL SCHOOL
Manisha Brahmachary
Associate Director,
Sanofi USA
Manoj Kandpal
Director of Research Bioinformatics,
The Rockefeller University
Marina Bleck
Principal Scientist,
Boehringer Ingelheim Pharmaceuticals, Inc.
Matt Kanke
Senior Scientist,
Amgen
Mehdi Damaghi
Assistant Professor,
Stony Brook University
Mena Kamel
Computational Scientist,
Sanofi
Mike G Makrigiorgos
Director,
Dana-Farber Cancer Institute
Nikolai Slavov
Professor,
Northeastern University
Nir Ben Chetrit
Principal Investigator,
Weill Cornell Medicine
Noriko Satake
Professor,
UC Davis
Priyank Patel
Senior Scientist,
Boehringer Ingelheim RCV GmbH & Co KG
Rajib Schubert
Assistant Professor, KAIST,
KAIST
Rigel Chan
Assistant professor,
UMass Chan Medical School
Ruslan Sadreyev
Director of Bioinformatics,
Massachusetts General Hospital
Ruslan Strogantsev
Staff Scientist,
OHSU
Sammy Ferri-Borgogno
Assistant Professor,
Anderson Cancer Center
Seungpyo Hong
Professor,
University of Wisconsin-Madison
Shoh Asano
Senior Principal Scientist,
Pfizer
Shuqiang Li
Lead Scientist, Translational Immunogenomic Laboratory,
Dana-Farber Cancer Institute
Silvia Siso
Scientist-Pathologist,
AbbVie
Stephen T Wong
Associate Director,
Houston Methodist Hospital
Sydney Lavoie
Principle Scientist,
Pfizer
Theodore Perkins
Senior Scientist,
Ottawa Health Research Institute
Tien Phan-Everson
Scientist II,
Allen Institute for Immunology
William Stephenson
Principal Scientist, Technology,
Genentech
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xiang Chen
Associate Member Computational Biology,
St. Jude Children's Research Hospital
Xiaofeng Jiang
Senior Scientist,
EMD Serono
Yan Tang
Assistant Professor,
Brigham & Women’s Hospital
Yasser Riazalhosseini
Associate Professor,
McGill University
Yesim Gokmen-Polar
Associate Professor,
Emory University School of Mediicne
Yu Tian
Director,
Abbvie
Yuhwa Lo
Professor,
University of California
Zhaleh Safikhani
Principal Scientist,
AbbVie
Zongmei Gao
Senior Scientist,
AbbVie

Interested in Sponsoring?

Our extensive and engaged community extends across large, mid-size and emerging companies within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Latest Resources

New Research From Indivumed Tx Highlights Importance of Snap Freezing Tumour Samples in Target Discovery and Cancer Therapy Development

Tumour samples which were frozen after more than ten minutes were significantly different in molecular biology to samples which were frozen in less than 10 minutes.

National University of Singapore Unveil Novel Single-Cell RNA Analysis Technique

The novel technique effectively denoises scRNA-seq data by fitting a low-dimensional manifold in the high-dimensional space.

AI Analysis of Patient Serum Presents Promising New Lyme Disease Diagnosis Tool

The AI-enabled immunological approach aims to bring accurate diagnoses faster and sooner after potential infection.

Novel Proteomics Biomarkers Show Potential for TB Lateral Flow Test

Earlier diagnosis of tuberculosis using an easy to use proteomic panel could save millions of lives from the disease.

The Dawn and Future of Spatial Transcriptomics

Adding positional context to the transcriptomics techniques was a breakthrough that would beckon in a new age of biopsy analysis. Now, integration with AI is the latest transformational addition to the field.

Avicenna.AI Algorithms Pass EU Medical Devices Regulations

Compliance with MDR 2017/745 medical device regulation is a critical step toward European Union CE-mark authorisation.
ScipioBio

 

"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."


Chief Business Officer
Scipio Bio

b6fc1bbe-f2c7-48f4-ab7b-860f705182f9-2-5668375logo-logo-levitasbio-R-full-color-(1)

 

"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."

Senior Product Marketing Manager
Levitasbio

BD Logo-1

 

"NextGen Omics US was well organised, with highly relevant and enaged attendees."


Senior Sales Specalist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company

Exact Sciences Logo

"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."


Regional Oncogenomic Liaison

Exact Sciences

Allumiqs

 

"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"


Digital Marketing Manager

Allumiqs

Plan Your Visit

Sheraton Boston Hotel
39 Dalton Street, Boston, Massachusetts, USA, 02199

Directions

 

By Air
The Sheraton Boston Hotel is conveniently located near Boston Logan International Airport (BOS), just a 15–20-minute drive away.

  • By Public Transport: Take the SL1 (Silver Line) bus from the airport to South Station (free). From South Station, transfer to the MBTA Green Line (E Branch) towards Heath Street and alight at Prudential Station, a short walk from the hotel.
  • By Shuttle Service: Airport shuttles are available; book in advance for door-to-door service.

For more information on airport services, visit the Logan International Airport website.

 

By Tram
Take the Green Line (B, C, or D) to Hynes Convention Center Station. The hotel is a short 3-minute walk from the station. Exit the station, head west along Massachusetts Avenue, and you’ll see the hotel on Dalton Street.

 

By Bus
Several MBTA bus routes stop near the hotel. Use routes 1, 39, or 55 to reach the Hynes Convention Center area. From the bus stop, it’s a quick walk to the hotel on Dalton Street.


Plan your trip using the MBTA website or app for real-time schedules.

 

By Rail
Getting to the Sheraton Boston Hotel by rail is simple and convenient. The hotel is located near major train stations in Boston, making it easily accessible. If arriving via Amtrak, disembark at Back Bay Station, which is just a 10-minute walk from the hotel. Alternatively, you can take a short taxi or rideshare trip. For those travelling on the MBTA Commuter Rail, Back Bay Station also serves as a central hub.


If you arrive at South Station, Boston’s main rail terminal, you can transfer to the Orange Line subway and travel to Back Bay Station in approximately 5 minutes. From there, follow the walking route to the Sheraton Boston Hotel. For added convenience, the hotel is also connected to the Prudential Center, which has easy access points if you’re navigating through the city’s pedestrian pathways.

Be sure to check train schedules and plan your journey ahead. For detailed directions, refer to the MBTA or Amtrak websites.

 

By Car

The Sheraton Boston Hotel is conveniently located in the heart of Boston, at 39 Dalton Street. For the easiest route, we recommend using GPS for real-time directions, ensuring an efficient journey.

When travelling by car, consider that the surrounding area can experience heavy traffic, especially during peak hours. It’s advisable to allow extra time for travel to account for potential delays.


Tip
: Due to Boston's busy streets and ongoing construction, we suggest checking traffic updates and planning your route in advance.

 

Parking

Sheraton Boston offers valet parking at a daily rate of $70. More details can be found on their website here.

Ensure to check for any changes or availability via the hotel's website.

Oxford Global does not have any contracted rooms at the Sheraton Boston Hotel. However, the hotel should have rooms available at their standard rates. We encourage you to contact the hotel directly for availability and pricing.

 

Below is a list of nearby hotels that you may find convenient for your stay:

Please note: While we have provided this list for your convenience, we strongly recommend conducting independent research to ensure that the accommodation suits your specific needs and preferences. Rates and availability may vary, so we suggest booking early to secure your stay.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Omics & Spatial Biology US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch